Kerri-Ann Norton1, Aleksander S Popel2, Niranjan B Pandey1. 1. Department of Biomedical Engineering, School of Medicine, Johns Hopkins University Baltimore, MD 21205, USA. 2. Department of Biomedical Engineering, School of Medicine, Johns Hopkins University Baltimore, MD 21205, USA ; Department of Oncology and The Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University Baltimore, MD, USA.
Abstract
INTRODUCTION: Tumor heterogeneity is a well-established concept in cancer research. In this paper, we examine an additional type of tumor cell heterogeneity - tumor cell-surface receptor heterogeneity. METHODS: We use flow cytometry to measure the frequency and numbers of cell-surface receptors on triple negative breast cancer cell lines. RESULTS: We find two distinct populations of human triple-negative breast cancer cells MDA-MB-231 when they are grown in culture, one with low surface levels of various chemokine receptors and a second with much higher levels. The population with high surface levels of these receptors is increased in the more metastatic MDA-MB-231-luc-d3h2ln cell line. CONCLUSION: We hypothesize that this high cell-surface receptor population is involved in metastasis. We find that the receptor high populations can be modulated by tumor conditioned media and IL6 treatment indicating that the tumor microenvironment is important for the maintenance and sizes of these populations.
INTRODUCTION:Tumor heterogeneity is a well-established concept in cancer research. In this paper, we examine an additional type of tumor cell heterogeneity - tumor cell-surface receptor heterogeneity. METHODS: We use flow cytometry to measure the frequency and numbers of cell-surface receptors on triple negative breast cancer cell lines. RESULTS: We find two distinct populations of human triple-negative breast cancer cells MDA-MB-231 when they are grown in culture, one with low surface levels of various chemokine receptors and a second with much higher levels. The population with high surface levels of these receptors is increased in the more metastatic MDA-MB-231-luc-d3h2ln cell line. CONCLUSION: We hypothesize that this high cell-surface receptor population is involved in metastasis. We find that the receptor high populations can be modulated by tumor conditioned media and IL6 treatment indicating that the tumor microenvironment is important for the maintenance and sizes of these populations.
Authors: Otto Metzger-Filho; Andrew Tutt; Evandro de Azambuja; Kamal S Saini; Giuseppe Viale; Sherene Loi; Ian Bradbury; Judith M Bliss; Hatem A Azim; Paul Ellis; Angelo Di Leo; José Baselga; Christos Sotiriou; Martine Piccart-Gebhart Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: Marco Velasco-Velázquez; Xuanmao Jiao; Marisol De La Fuente; Timothy G Pestell; Adam Ertel; Michael P Lisanti; Richard G Pestell Journal: Cancer Res Date: 2012-05-25 Impact factor: 12.701
Authors: Melanie A Krook; Lauren A Nicholls; Christopher A Scannell; Rashmi Chugh; Dafydd G Thomas; Elizabeth R Lawlor Journal: Mol Cancer Res Date: 2014-03-20 Impact factor: 5.852
Authors: Lorenzo Melchor; Gemma Molyneux; Alan Mackay; Fiona-Ann Magnay; María Atienza; Howard Kendrick; Daniel Nava-Rodrigues; María Ángeles López-García; Fernanda Milanezi; Kirsty Greenow; David Robertson; José Palacios; Jorge S Reis-Filho; Matthew J Smalley Journal: J Pathol Date: 2014-06 Impact factor: 7.996
Authors: P M Peiris; F He; G Covarrubias; S Raghunathan; O Turan; M Lorkowski; B Gnanasambandam; C Wu; W P Schiemann; E Karathanasis Journal: Nanoscale Date: 2018-04-19 Impact factor: 7.790
Authors: Yongfeng Zhao; Bo Pang; Hannah Luehmann; Lisa Detering; Xuan Yang; Deborah Sultan; Scott Harpstrite; Vijay Sharma; Cathy S Cutler; Younan Xia; Yongjian Liu Journal: Adv Healthc Mater Date: 2016-02-10 Impact factor: 9.933
Authors: José Esparza-López; Pier A Ramos-Elías; Andrea Castro-Sánchez; Leticia Rocha-Zavaleta; Elizabeth Escobar-Arriaga; Alejandro Zentella-Dehesa; Eucario León-Rodríguez; Heriberto Medina-Franco; María de Jesus Ibarra-Sánchez Journal: BMC Cancer Date: 2016-09-20 Impact factor: 4.430
Authors: Matthew J Billard; David J Fitzhugh; Joel S Parker; Jaime M Brozowski; Marcus W McGinnis; Roman G Timoshchenko; D Stephen Serafin; Ruth Lininger; Nancy Klauber-Demore; Gary Sahagian; Young K Truong; Maria F Sassano; Jonathan S Serody; Teresa K Tarrant Journal: PLoS One Date: 2016-04-06 Impact factor: 3.240
Authors: Gil Covarrubias; Anthony Cha; Abdelrahman Rahmy; Morgan Lorkowski; Vindya Perera; Bernadette O Erokwu; Chris Flask; Pubudu M Peiris; William P Schiemann; Efstathios Karathanasis Journal: PLoS One Date: 2018-10-18 Impact factor: 3.240
Authors: Yang Shen; B U Sebastian Schmidt; Hans Kubitschke; Erik W Morawetz; Benjamin Wolf; Josef A Käs; Wolfgang Losert Journal: Cancer Converg Date: 2020-02-03